Lanean...
Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab
Objective. The aim was to assess the efficacy of rituximab for the cutaneous manifestations of adult DM and JDM. Methods. Patients with refractory adult DM (n = 72) and JDM (n = 48) were treated with rituximab in a randomized placebo-phase-controlled trial [either rituximab early drug (week 0/1) or...
Gorde:
| Argitaratua izan da: | Rheumatology (Oxford) |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5854037/ https://ncbi.nlm.nih.gov/pubmed/27837048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kew396 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|